title: Hepatitis C virus screening to reveal a better picture of infection.
abstract: Antiviral therapy for hepatitis C virus (HCV) infection will be the next revolution in clinical virology. Sensible planning for treatment is needed, starting with population-screening policies ideally using the HCV core antigen. This will result in a more defined picture of the silent spread of HCV.
authors.affiliation: Unit of Microbiology and Virology, Department of Clinical and Experimental Medicine, Faculty and Medicine and Surgery, University of Parma, Italy, Viale Antonio Gramsci, 14-43126 Parma, Italy.
authors.forename: Maria Cristina
authors.initials: MC
authors.lastname: Medici
authors.affiliation: Scientific Affairs, Abbott Diagnostics, via Amsterdam, 125-00144 Roma, Italy.
authors.forename: Claudio
authors.initials: C
authors.lastname: Galli
authors.affiliation: Unit of Microbiology and Virology, Department of Clinical and Experimental Medicine, Faculty and Medicine and Surgery, University of Parma, Italy, Viale Antonio Gramsci, 14-43126 Parma, Italy. Electronic address: adriana.calderaro@unipr.it.
authors.forename: Adriana
authors.initials: A
authors.lastname: Calderaro
mesh_terms: D005060:Europe; D016174:Hepacivirus / Q000302:isolation & purification / Q000472:pathogenicity; D006526:Hepatitis C / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D019698:Hepatitis C, Chronic / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology* / Q000517:prevention & control; D006801:Humans; D008403:Mass Screening / Q000191:economics; D014481:United States
keywords: hepatitis C virus; population screening; testing algorithms